FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 57 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $614,078 | -12.9% | 81,768 | +2.4% | 0.00% | – |
| Q2 2023 | $705,279 | +1.9% | 79,873 | -28.3% | 0.00% | – |
| Q1 2021 | $692,000 | -4.8% | 111,372 | +14.2% | 0.00% | – |
| Q4 2020 | $727,000 | +40.9% | 97,508 | +14.5% | 0.00% | – |
| Q3 2020 | $516,000 | -31.6% | 85,170 | -5.6% | 0.00% | – |
| Q2 2020 | $754,000 | +244.3% | 90,264 | +100.3% | 0.00% | – |
| Q1 2019 | $219,000 | -17.7% | 45,067 | +8.3% | 0.00% | – |
| Q4 2018 | $266,000 | -25.5% | 41,609 | -4.3% | 0.00% | – |
| Q3 2018 | $357,000 | -15.8% | 43,488 | +7.1% | 0.00% | – |
| Q2 2018 | $424,000 | – | 40,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |